Amarin Corp plc

The US Supreme Court requested the Solicitor General’s input in Hikma ’s case on a skinny-label generic of Amarin ’s Vascepa (icosapent ethyl), adding extra gravity to the issue after a federal appe

Amarin is continuing to mull the possibility of launching an authorized generic version of its Vascepa (icosapent ethyl) in the US, closing in on five years after the first abbreviated new drug applic

Jacqueline Corrigan-Curay, acting head of the US Food and Drug Administration’s Center for Drug Evaluation and Research, will retire, allowing Commissioner Martin Makary to fill another influential se

The US Supreme Court has requested input from the country’s solicitor general in Hikma’s induced infringement skinny-label generic Vascepa (icosapent ethyl) case, giving extra gravity to the matter fo